V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220016290 | 220017265 | 1.84 | 81 | Curative (C) | 2014-12-01 | 2015-02-09 | FLAG + Idarubicin | N | N | 220023175 | FLAG + IDARUBICIN |
| 220016291 | 220006124 | 0 | 92 | Curative (C) | 2014-01-17 | 2014-01-21 | AML17 TRIAL | 02 | N | 220023180 | AML17 TRIAL |
| 220016292 | 220006126 | 1.62 | null | Palliative (P) | 2015-02-24 | 2015-06-21 | FLAG + Idarubicin | 99 | N | 220023182 | FLAG + IDARUBICIN |
| 220016293 | 220006127 | 1.57 | 78.1 | Curative (C) | null | 2014-09-20 | AML17 TRIAL | null | N | 220023202 | AML17 TRIAL |
| 220016294 | 220019472 | 1.78 | 86 | Adjuvant (A) | 2016-12-11 | 2016-12-11 | FLAG + Idarubicin | null | N | 220023206 | FLAG + IDARUBICIN |
| 220016298 | 220006131 | 1.56 | 69.2 | Curative (C) | 2014-10-13 | 2014-10-13 | AML17 TRIAL | 02 | N | 220023241 | AML17 TRIAL |
| 220016299 | 220006134 | 1.76 | 90.8 | Palliative (P) | 2014-01-16 | 2014-04-24 | AML17 TRIAL | N | N | 220023242 | AML17 TRIAL |
| 220016300 | 220006136 | 1.68 | 125 | Curative (C) | 2016-06-05 | 2016-06-28 | AML Interim Guidelines FLAG-Ida | N | N | 220023257 | FLAG + IDARUBICIN |
| 220016301 | 220006139 | 1.64 | 92.3 | Curative (C) | 2014-05-21 | 2014-05-21 | AML17 TRIAL | 02 | N | 220023264 | AML17 TRIAL |
| 220016302 | 220006141 | 1.77 | 24.9 | Curative (C) | 2017-06-03 | 2017-06-22 | FLAG + Idarubicin | N | N | 220023266 | FLAG + IDARUBICIN |
| 220016303 | 220006143 | 1.64 | 51.7 | null | 2015-06-26 | 2015-08-07 | AML17 TRIAL | N | N | 220023272 | AML17 TRIAL |
| 220016304 | 220020733 | 1.63 | 66 | Curative (C) | 2017-02-04 | 2017-06-21 | FLAG + Idarubicin | 02 | N | 220023288 | FLAG + IDARUBICIN |
| 220016305 | 220017273 | 1.74 | null | Not known (9) | 2015-02-01 | 2015-03-08 | AML17 TRIAL | N | N | 220023293 | AML17 TRIAL |
| 220016306 | 220006149 | 1.78 | 41.3 | Curative (C) | 2015-05-25 | 2015-09-12 | AML17 TRIAL | Y | null | 220023301 | AML17 TRIAL |
| 220016307 | 220019475 | 1.8 | 73.4 | Adjuvant (A) | 2013-05-14 | 2013-07-12 | AML17 TRIAL | N | N | 220023312 | AML17 TRIAL |
| 220016308 | 220013295 | 1.83 | 78.9 | Curative (C) | 2013-08-21 | 2013-08-21 | AML17 TRIAL | 2 | N | 220023326 | AML17 TRIAL |
| 220016309 | 220006156 | 1.69 | 80 | Curative (C) | 2017-01-12 | 2017-01-12 | FLAG + Idarubicin | 02 | N | 220023329 | FLAG + IDARUBICIN |
| 220016310 | 220013297 | 0 | 82.4 | Disease modification (D) | 2013-03-19 | 2013-05-17 | FLAG + Idarubicin | Y | N | 220023340 | FLAG + IDARUBICIN |
| 220016311 | 220006160 | 1.71 | 28.85 | Palliative (P) | 2015-05-23 | 2015-05-31 | FLAG + Idarubicin | 02 | N | 220023340 | FLAG + IDARUBICIN |
| 220016312 | 220013300 | 1.7 | 59.6 | Adjuvant (A) | 2015-04-20 | 2015-04-27 | AML17 TRIAL | N | N | 220023343 | AML17 TRIAL |
| 220016313 | 220006162 | 1.79 | 95 | Curative (C) | 2017-11-27 | 2017-11-28 | FLAG + Idarubicin | Y | N | 220023346 | FLAG + IDARUBICIN |
| 220016314 | 220006164 | 1.6 | 72.7 | Palliative (P) | 2016-02-09 | 2016-02-09 | FLAG + Idarubicin | 02 | null | 220023346 | FLAG + IDARUBICIN |
| 220016315 | 220006167 | 1.73 | 87 | Curative (C) | 2017-07-03 | 2017-07-07 | FLAG + Idarubicin | N | N | 220023395 | FLAG + IDARUBICIN |
| 220016317 | 220006169 | 1.57 | 80 | Curative (C) | 2013-06-08 | 2013-07-23 | AML17 TRIAL | 02 | N | 220023409 | AML17 TRIAL |
| 220016318 | 220006171 | 1.68 | null | Not known (9) | null | 2018-11-17 | FLAG + Idarubicin | N | N | 220023414 | FLAG + IDARUBICIN |
| 220016319 | 220019479 | null | null | Curative (C) | null | 2016-11-11 | FLAG + Idarubicin | N | N | 220023416 | FLAG + IDARUBICIN |
| 220016320 | 220013310 | 1.61 | 52.2 | Curative (C) | 2015-06-25 | 2015-07-22 | AML17 TRIAL | N | N | 220023416 | AML17 TRIAL |
| 220016322 | 220006174 | 1.72 | 67 | Curative (C) | 2013-11-22 | 2013-11-26 | AML17 TRIAL | 02 | null | 220023447 | AML17 TRIAL |
| 220016323 | 220006177 | 1.82 | 72.6 | Curative (C) | 2015-05-25 | 2015-05-31 | AML17 TRIAL | 02 | N | 220023465 | AML17 TRIAL |
| 220016324 | 220019482 | 1.7 | 104.5 | Curative (C) | 2017-11-19 | 2017-11-20 | AML17 TRIAL | 99 | N | 220023471 | AML17 TRIAL |
| 220016325 | 220019483 | 1.85 | 131.2 | Curative (C) | 2016-07-04 | 2016-08-21 | FLAG + Idarubicin | N | N | 220023478 | FLAG + IDARUBICIN |
| 220016326 | 220006186 | 1.63 | 117 | Curative (C) | 2013-04-06 | 2013-07-02 | AML17 TRIAL | N | N | 220023485 | AML17 TRIAL |
| 220016327 | 220006187 | 0 | 88.95 | Curative (C) | null | 2018-04-27 | AML Interim Guidelines FLAG-Ida | null | N | 220023489 | FLAG + IDARUBICIN |
| 220016328 | 220006191 | 1.69 | null | Curative (C) | 2014-12-14 | 2014-12-23 | FLAG + Idarubicin | N | null | 220023491 | FLAG + IDARUBICIN |
| 220016329 | 220006193 | 1.6 | 54 | Curative (C) | 2016-11-16 | 2016-11-16 | AML17 TRIAL | N | N | 220023497 | AML17 TRIAL |
| 220016330 | 220006196 | 1.88 | 71.4 | Disease modification (D) | 2016-04-20 | 2016-06-08 | AML17 TRIAL | Y | N | 220023499 | AML17 TRIAL |
| 220016331 | 220006197 | 1.62 | 51.7 | Curative (C) | 2014-04-07 | 2014-04-07 | FLAG + Idarubicin | 02 | N | 220023517 | FLAG + IDARUBICIN |
| 220016332 | 220017295 | 1.78 | 69.7 | Curative (C) | 2013-12-20 | 2014-02-19 | AML17 TRIAL | Y | null | 220023525 | AML17 TRIAL |
| 220016333 | 220006201 | null | 64.6 | Curative (C) | 2015-02-18 | 2015-03-29 | AML17 TRIAL | Y | N | 220023541 | AML17 TRIAL |
| 220016334 | 220006203 | null | 65.4 | Curative (C) | 2014-07-02 | 2014-09-22 | FLAG + Idarubicin | N | N | 220023551 | FLAG + IDARUBICIN |
| 220016335 | 220006205 | 1.5 | 76.3 | Curative (C) | 2015-07-31 | 2015-09-14 | AML17 TRIAL | 01 | N | 220023563 | AML17 TRIAL |
| 220016336 | 220006206 | 1.77 | 80 | Curative (C) | 2017-07-25 | 2017-07-25 | AML17 TRIAL | N | N | 220023564 | AML17 TRIAL |
| 220016337 | 220019485 | null | 79.399 | Curative (C) | 2018-04-07 | 2018-04-10 | AML17 TRIAL | N | N | 220023564 | AML17 TRIAL |
| 220016339 | 220006208 | 1.85 | null | Curative (C) | 2017-06-28 | 2017-09-05 | FLAG + Idarubicin | Y | Y | 220023577 | FLAG + IDARUBICIN |
| 220016340 | 220006210 | null | null | Curative (C) | 2015-02-13 | 2015-04-12 | FLAG + Idarubicin | N | N | 220023589 | FLAG + IDARUBICIN |
| 220016341 | 220006212 | 1.94 | 80 | Curative (C) | 2016-12-23 | 2016-12-23 | FLAG + Idarubicin | 1 | N | 220023599 | FLAG + IDARUBICIN |
| 220016342 | 220006214 | 1.66 | 101.3 | Curative (C) | 2016-02-13 | 2016-02-13 | AML Interim Guidelines FLAG-Ida | 1 | N | 220023606 | FLAG + IDARUBICIN |
| 220016343 | 220006217 | 1.7 | 83 | Curative (C) | 2012-07-18 | 2012-09-02 | FLAG + Idarubicin | Y | N | 220023614 | FLAG + IDARUBICIN |
| 220016344 | 220006219 | 1.76 | 98 | Curative (C) | 2012-06-30 | 2013-09-16 | FLAG + Idarubicin | N | N | 220023620 | FLAG + IDARUBICIN |
| 220016345 | 220006221 | 1.6 | 64 | Disease modification (D) | 2017-03-31 | 2017-06-06 | FLAG + Idarubicin | N | N | 220023625 | FLAG + IDARUBICIN |